Articles On Alchemia (ASX:ACL)

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

ASX healthcare shares finished in the red on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) falling 1.11% while the S&P/ASX 200 Index (ASX: XJO) also tumbled 0.5%. In a recent note, fund manager IML identified th...

S&P/ASX All Ordinaries (ASX: XAO) shares are up 0.58% to 8,606.1 points at the time of writing on Thursday. Meantime, Tamim Asset Management has issued a note on three ASX All Ords shares to buy. The broker says these stocks offe...

  US stocks climbed overnight, with the S&P 500 reaching a new record following the release of encouraging U.S. economic data. The broad market index rose 0.40 per cent to 5,745.37, achieving both an all-time high during the session and...

S&P/ASX All Ordinaries Index (ASX: XAO) share Australian Clinical Labs Ltd (ASX: ACL) is trading 2.1% higher at $3.40 per share. The All Ords Index is also up 0.84% to 8,264.3 points at the time of writing. It seems investors in t...

Fund manager Crescent Capital has announced its complete exit from Australian Clinical Labs (ASX: ACL), marking a significant shift in its investment strategy. Crescent Capital has divested its 30.12 percent stake in ACL through a block tra...

In a notable rebound, the Australian share market demonstrated resilience as it saw broad gains following a rally on Wall Street. The benchmark S&P/ASX 200 index advanced by 0.6 percent, or 44.30 points, to reach 8032.20. This brings it...

Highlights: ASX 200 futures indicate a positive opening with a rise of 50 points, driven by a strong overnight performance in US markets and an uptick in commodity prices. The US core CPI came in hotter-than-expected, yet markets reb...

  US stocks took a sharp downturn on Tuesday as technology shares faltered and new economic data reignited concerns about the health of the economy. The Dow Jones Industrial Average fell by 626.15 points, or 1.51 per cent, closing at 40,936...

US stocks took a sharp downturn on Tuesday as technology shares faltered and new economic data reignited concerns about the health of the economy. The Dow Jones Industrial Average fell by 626.15 points, or 1.51 per cent, closing at 40,936.9...

The ASX200 closed down more than 2% at 7,943 points. Despite hitting a fresh all-time record yesterday, the bourse retreated down below the 8,000 level. The ASX200 dipped along with Asian markets as stocks were hammered. The magnitude...

Monitoring short interest can provide valuable insights into market sentiment and potential concerns about company performance. This week’s ASIC short position report highlights the ASX shares currently attracting the most attention from sh...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Highlights:  ASX 200 futures fall 1.09%, mirroring losses in major US indices and mixed global economic updates.  Big Tech stocks showed mixed results overnight, with Meta and Nvidia gaining, while Apple, Alphabet, and Amazon decline...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Some experts have revealed where they see value within the S&P/ASX 300 Index (ASX: XKO) share landscape. Share prices are always changing, so when valuations adjust, it can open up opportunities if something moves from being fair va...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The Australian share market may be trading near its record high but that hasn't stopped some ASX 300 shares from hitting new 52-week lows. Three such shares that have made these unwelcome milestones are listed below. Is this recent weakness...

The biomedical treatment of disease and injury is what we call Pathology. Needles. Blood. Tissue. Other gross things. Etc. From the commonplace lab services which take and test our blood – to the cutting edge biological research of medical...

The biomedical treatment of disease and injury is what we call Pathology. Needles. Blood. Tissue. Other gross things. Etc. From the common place lab services which take and test our blood – to the cutting edge biological research of medical...

  US stocks slid as mixed economic data raised fears that stagflation may rear its ugly head, as growth numbers came in weaker than expected and price growth higher than expected. The Dow Jones fell 0.98 per cent. The S&P 500 closed dow...

US stocks slid as mixed economic data raised fears that stagflation may rear its ugly head, as growth numbers came in weaker than expected and price growth higher than expected. The Dow Jones fell 0.98 per cent. The S&P 500 closed down...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level...

  US markets bounced back after three consecutive losing sessions & extended their first quarter advance. The S&P 500 closed at a new record high finishing the day up 0.86 per cent at 5,248. The Dow Jones closed up 1.2 per cent and...

US markets bounced back after three consecutive losing sessions & extended their first quarter advance. The S&P 500 closed at a new record high finishing the day up 0.86 per cent at 5,248. The Dow Jones closed up 1.2 per cent and th...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level...

Cheaper homes and ASX small-cap shares are delivering superior capital growth to investors in 2024, new figures show. ASX small-cap shares are defined as companies with a market capitalisation of between a few hundred thousand and $2 bill...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level...

It has been another busy day of earnings releases on Wednesday. Some results have gone down well with investors, others have not. For example, listed below are two ASX 300 shares that are being sold off following the release of their respe...

It's fair to say that ASX healthcare shares have flummoxed investors over the past couple of years. As interest rates headed up and consumers closed their wallets, many fund managers expected the health sector to outperform because of the...

After two years of shocking underperformance, ASX small-cap shares made a stunning comeback towards the end of 2023. "Despite the negativity that pervaded most of last year, the small cap market ultimately managed to deliver solid returns...

ASX healthcare share Australian Clinical Labs Ltd (ASX: ACL) has seen a large sell-off this year. So is this an opportunity to buy the dip? As we can see on the chart below, since March 2023, the Australian Clinical Labs share price has sh...

The nation’s privacy watchdog has launched civil proceedings against Australian Clinical Labs (ASX: ACL) over a Medlab hack that saw more than 223,000 patients and staff have their health records and credit card numbers stolen late last yea...

One of the biggest potential reasons for massive price movement in an ASX stock is mergers and acquisitions. That's because, in an instant, the nature of the whole business can change. If it's offloading an unprofitable activity, then the...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.051% to 7068.80. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify...

Pilbara Minerals has become the most shorted ASX stock as price of lithium falls from 2022 highs Flight Centre the second most shorted ASX stock, despite a turnaround in its profits in FY23 AI play Brainchip Holdings booted from S&P AS...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.46% to 7186.50. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify....

The ASX 200 climbed on Thursday Iron ore, uranium, and coal stocks mostly rallied Australian employment rate held steady in August, blowing past forecasts   Local shares climbed on Thursday as the labour market data blew past predictions....

The $1.58 billion off-market takeover bid for pathology company Healius (ASX: HLS) has been put on hold by Australian Clinical Labs (ASX: ACL) pending a decision by the competition watchdog and a review of the target’s FY23 financial statem...

  The Dow Jones Industrial Average fell Wednesday as traders absorbed a hotter-than-expected August core inflation print. The Dow lost 70.46 points, or 0.20 per cent, to 34,575.53 for its second straight decline. Meanwhile, the S&P 500...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down 0.74% to 7153.90. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify...

The Healius Ltd (ASX: HLS) share price finished the session on Wednesday up 7.75% after the company released its full-year FY23 results. Healius reported an underlying profit of just $25.7 million, which is a 91.6% fall year over year. De...